Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Oflowel
Oflowel is a clinically proven ophthalmic solution containing Ofloxacin 0.3%, designed to treat bacterial eye infections. It offers rapid relief from symptoms associated with infections such as redness, itching, and irritation, providing targeted action directly at the site of infection. Oflowel is an effective, well-tolerated antibiotic that can be used for both acute and chronic bacterial eye conditions.
Uses of Oflowel
Oflowel is indicated for the treatment of:
Bacterial Conjunctivitis (Pink Eye)
Bacterial Blepharitis (Eyelid Inflammation)
Keratitis (Corneal Infection)
Other Ocular Infections Caused by Susceptible Bacteria
Benefits of Oflowel
Broad-Spectrum Antibiotic Action Against a Range of Bacteria
Rapid Relief from Redness, Swelling, and Irritation
Effective Treatment for Various Ocular Infections
Minimal Systemic Absorption, Localized Effectiveness
Clinically Proven to Improve Symptoms Quickly
Mechanism of Action of Oflowel
Oflowel works by inhibiting bacterial DNA gyrase, an enzyme involved in the supercoiling of bacterial DNA. This inhibition prevents bacterial DNA replication and cell division, leading to bacterial death. Its rapid bactericidal action ensures effective control of the infection.